Stocks making the biggest moves midday: Merck, Bristol-Myers Squibb, Align Technology and more

  • 📰 CNBC
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 72%

Belgique Nouvelles Nouvelles

Belgique Dernières Nouvelles,Belgique Actualités

These are the stocks posting the largest moves in midday trading.

Check out the companies making headlines in midday trading. Bunge — Shares of the global crop trader and processor popped 5.2% after the company lifted its 2023 outlook and reported better-than-expected profit for the third quarter. Bunge's earnings were lower year-on-year, however. Comcast — Comcast shares fell 6.3% after the telecom giant reported a loss in high-speed broadband subscribers. Advertising revenue from NBCUniversal was also weak.

Align Technology — The medical device maker dropped 25% on Thursday after missing Wall Street forecasts in the third quarter and offering weak guidance for current-quarter revenue. Align posted $2.14 in earnings per share excluding items and $960 million in revenue in the third quarter. Analysts polled by LSEG expected earnings of $2.26 per share and revenue at $995 million. American Tower Corporation — The American real estate investment trust added 8.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

 /  🏆 12. in BE
 

Merci pour votre commentaire. Votre commentaire sera publié après examen.

Belgique Dernières Nouvelles, Belgique Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Bristol-Myers Squibb earnings top estimatesCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
La source: MarketWatch - 🏆 3. / 97 Lire la suite »

Bristol Myers Squibb earnings top estimates even as top-selling drug fights generic competitionBristol Myers Squibb’s revenue was in line with estimates, but fell slightly from the same period last year due to lower sales of blood cancer drug Revlimid.
La source: CNBC - 🏆 12. / 72 Lire la suite »

Japanese stocks rise for second session as Hong Kong stocks gainSupported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with unparalleled accuracy.
La source: MarketWatch - 🏆 3. / 97 Lire la suite »